8-KShareholder Matters

INTEL CORP 8-K Report, Shareholder Vote Results (May 9, 2024)

Filed May 9, 2024For Securities:INTC

Summary

Intel Corporation (INTC) held its Annual Meeting of Stockholders on May 7, 2024, where a substantial 82.5% of outstanding shares were represented, indicating strong shareholder engagement. The meeting's primary focus was on voting on several proposals, including the election of directors, ratification of the independent auditor, and advisory votes on executive compensation and various stockholder proposals. All incumbent directors were overwhelmingly elected, and the selection of the independent registered public accounting firm was ratified. Similarly, the advisory vote to approve executive compensation received majority support from shareholders. However, the meeting also saw the rejection of three significant stockholder proposals. These included proposals on establishing a Corporate Financial Sustainability Board Committee, a Risk Report concerning state abortion regulations, and an Excessive Golden Parachute Approval Policy. The voting outcomes on these proposals suggest that the majority of shareholders did not support these specific initiatives as presented by the company's management.

Key Highlights

  • 1Strong shareholder turnout with 82.5% of outstanding shares represented at the Annual Meeting.
  • 2All nominated directors were overwhelmingly elected by shareholders.
  • 3The selection of the independent registered public accounting firm was ratified by a significant majority.
  • 4Shareholders provided advisory approval for the compensation of Named Executive Officers.
  • 5Three stockholder proposals were not approved: establishment of a Corporate Financial Sustainability Board Committee, a Risk Report on state abortion regulations, and an Excessive Golden Parachute Approval Policy.
  • 6The voting results reflect substantial support for board nominations and executive compensation, while signaling shareholder dissent on the specific ESG and governance-related proposals.

Frequently Asked Questions